InspireMD, Inc. cash flow to debt ratio of -1.07K% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

InspireMD, Inc.'s free cash flow has decreased 57.99% from $-23.27M last year to $-36.77M, signaling decreasing performance

InspireMD, Inc.'s debt to equity ratio is 0.07, which means that the company's assets are healthy financed, signaling financial stability.

InspireMD, Inc.'s debt has increased relative to shareholder equity from 0.06 last year to 0.07 today, signaling weakened financials

InspireMD, Inc. has a net cash position, so leverage is healthy.

InspireMD, Inc.'s interest coverage ratio is -394.94, which means that the company struggles to meet interest obligations, signaling financial risk.

InspireMD, Inc.'s profit margin has increased (-24.64%) in the last year from -456.63% to -344.13%, signaling increasing performance

InspireMD, Inc.'s short-term assets of $61.47M exceed its short-term liabilities of $10.71M

InspireMD, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

InspireMD, Inc.'s return on equity of -81.52%, is lower than 15.00%, indicating bad performance

InspireMD, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

InspireMD, Inc. had positive net income in only 0 out of 5 years, indicating unstable earnings

InspireMD, Inc. has negative free cash flow, indicating the company is burning cash rather than generating it

InspireMD, Inc. has negative free cash flow, indicating cash burn

InspireMD, Inc.'s yearly earnings has decreased 52.43% since last year from $-32.01M to $-48.79M, signaling decreasing performance

InspireMD, Inc.'s yearly revenue has increased 28.11% since last year from $7.01M to $8.98M, signaling increasing performance

ROIC -108.39% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

InspireMD, Inc.'s 3-year revenue CAGR of 20.19% is positive, indicating growing revenue over the past 3 years

InspireMD, Inc. had revenue growth in 5 out of 5 years, indicating consistent revenue performance

InspireMD, Inc. had positive ROE in only 0 out of 5 years, indicating inconsistent returns on equity

InspireMD, Inc. has insufficient data to evaluate this check.

InspireMD, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

InspireMD, Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

InspireMD, Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable

InspireMD, Inc. is overvalued relative to its fair value price of -8.56 based on Earnings Fair Value model

InspireMD, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

InspireMD, Inc. has a price-to-book ratio of 1.35x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

InspireMD, Inc. has a price-to-sales ratio of 5.42x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue